Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis
Background: Increased oxidative stress and bronchial inflammation are important mechanisms in the pathophysiology of COPD. Aim: To investigate whether treatment with the inhaled corticosteroid fluticasone propionate (FP) or the anti-oxidative agent N-acetylcysteine (NAC) are effective in primary care patients. Methods: The study was a 3-year placebo-controlled randomised controlled trial preceded by a 3-month washout and 2-week prednisolone pre-treatment. Patients were (ex-)smokers with chronic...[Show more]
|Collections||ANU Research Publications|
|01_Schermer_Fluticasone_and_2009.pdf||493.42 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.